Page last updated: 2024-08-21

pyrazines and bq 3020

pyrazines has been researched along with bq 3020 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bialecki, R; Heys, C; Hunt, SJ; James, R; Kelly, E; Mellor, S; Palmer, S; Tang, E; Wilson, C; Wright, N	1

Other Studies

1 other study(ies) available for pyrazines and bq 3020

Article	Year
Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:3 Topics: Administration, Oral; Animals; Aorta; Binding, Competitive; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Male; Mice; Peptide Fragments; Pyrazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides	1999

Article

Year

Pharmacological profile of ZD1611, a novel, orally active endothelin ETA receptor antagonist.

The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:3

Topics: Administration, Oral; Animals; Aorta; Binding, Competitive; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Male; Mice; Peptide Fragments; Pyrazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides

1999